Clinical Trial Update: Efficacy Biomarkers of DAOIB for Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating efficacy biomarkers of DAOIB for dementia. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• DAOIB

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Dementia | Phase 2 | Status: RECRUITING